Literature DB >> 21377043

Metabolomic profiling of asthma: diagnostic utility of urine nuclear magnetic resonance spectroscopy.

Erik J Saude1, Christopher D Skappak, Shana Regush, Kim Cook, Amos Ben-Zvi, Allan Becker, Redwan Moqbel, Brian D Sykes, Brian H Rowe, Darryl J Adamko.   

Abstract

BACKGROUND: The ability to diagnose and monitor asthma on the basis of noninvasive measurements of airway cellular dysfunction is difficult in the typical clinical setting.
OBJECTIVE: Metabolomics is the study of molecules created by cellular metabolic pathways. We hypothesized that the metabolic activity of children with asthma would differ from healthy children without asthma. Furthermore, children having an asthma exacerbation would be different compared with children with stable asthma in outpatient clinics. Finally, we hypothesized that (1)H-nuclear magnetic resonance (NMR) would measure such differences using urine samples, one of the least invasive forms of biofluid sampling.
METHODS: Children (135 total, ages 4-16 years) were enrolled, having met the criteria of healthy controls (C), stable asthma in the outpatient clinic (AO), or unstable asthma in the emergency department (AED). Partial least squares discriminant analysis was performed on the NMR data to create models of separation (70 metabolites were measured/urine sample). Some NMR data were withheld from modeling to be run blindly to determine possible diagnostic accuracy.
RESULTS: On the basis of the model of AO versus C, 31 of 33 AO samples were correctly diagnosed with asthma (94% accuracy). Only 1 of 20 C samples was incorrectly labeled as asthma (5% misclassification). On the basis of the AO versus AED model, 31 of the 33 AO samples were correctly diagnosed as outpatient asthma (94% accurate).
CONCLUSION: This is the first report suggesting that (1)H-NMR analysis of human urine samples has the potential to be a useful clinical tool for physicians treating asthma.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377043     DOI: 10.1016/j.jaci.2010.12.1077

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  43 in total

1.  Metabolic alterations in the sera of Chinese patients with mild persistent asthma: a GC-MS-based metabolomics analysis.

Authors:  Chun Chang; Zhi-guo Guo; Bei He; Wan-zhen Yao
Journal:  Acta Pharmacol Sin       Date:  2015-11       Impact factor: 6.150

2.  Metabolomic profiling of lung function in Costa-Rican children with asthma.

Authors:  Rachel S Kelly; Yamini Virkud; Rachel Giorgio; Juan C Celedón; Scott T Weiss; Jessica Lasky-Su
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-07       Impact factor: 5.187

3.  Comparative analysis of creatinine and osmolality as urine normalization strategies in targeted metabolomics for the differential diagnosis of asthma and COPD.

Authors:  Mona M Khamis; Teagan Holt; Hanan Awad; Anas El-Aneed; Darryl J Adamko
Journal:  Metabolomics       Date:  2018-08-29       Impact factor: 4.290

Review 4.  Metabolomics approach in allergic and rheumatic diseases.

Authors:  Rossana Scrivo; Luca Casadei; Mariacristina Valerio; Roberta Priori; Guido Valesini; Cesare Manetti
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

5.  Identifying biomarkers for asthma diagnosis using targeted metabolomics approaches.

Authors:  William Checkley; Maria P Deza; Jost Klawitter; Karina M Romero; Jelena Klawitter; Suzanne L Pollard; Robert A Wise; Uwe Christians; Nadia N Hansel
Journal:  Respir Med       Date:  2016-10-21       Impact factor: 3.415

6.  Metabolomics reveals altered metabolic pathways in experimental asthma.

Authors:  Wanxing Eugene Ho; Yong-Jiang Xu; Fengguo Xu; Chang Cheng; Hong Yong Peh; Steven R Tannenbaum; W S Fred Wong; Choon Nam Ong
Journal:  Am J Respir Cell Mol Biol       Date:  2012-11-09       Impact factor: 6.914

Review 7.  A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.

Authors:  Kedir N Turi; Lindsey Romick-Rosendale; Kelli K Ryckman; Tina V Hartert
Journal:  J Allergy Clin Immunol       Date:  2017-05-04       Impact factor: 10.793

8.  Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.

Authors:  Nilanjana Ghosh; Priyanka Choudhury; Elavarasan Subramani; Dipanjan Saha; Sayoni Sengupta; Mamata Joshi; Rintu Banerjee; Sushmita Roychowdhury; Parthasarathi Bhattacharyya; Koel Chaudhury
Journal:  Metabolomics       Date:  2019-06-04       Impact factor: 4.290

Review 9.  Metabolic phenotyping in clinical and surgical environments.

Authors:  Jeremy K Nicholson; Elaine Holmes; James M Kinross; Ara W Darzi; Zoltan Takats; John C Lindon
Journal:  Nature       Date:  2012-11-15       Impact factor: 49.962

Review 10.  Personalised medicine and asthma diagnostics/management.

Authors:  Samuel J Wadsworth; Andrew J Sandford
Journal:  Curr Allergy Asthma Rep       Date:  2013-02       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.